{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T06:34:40Z","timestamp":1793169280914,"version":"4.5.0"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"37","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"the Excellent Young Scientist Grant (General Category), The Fourth Affiliated Hospital of Harbin Medical University","award":["HYDSYYXQN202408"],"award-info":[{"award-number":["HYDSYYXQN202408"]}],"id":[{"id":"https:\/\/ror.org\/02s7c9e98","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9,11]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Plasma lipid composition has been linked to multiple cancers, yet its causal contribution to gastric cancer and the potential intermediary role of immune cells remain unclear. We aimed to clarify these relationships and identify specific lipid and immune cell traits that either protect against or promote gastric cancer. We performed a 2-sample, 2-step Mendelian randomization analysis using summary statistics from large genome-wide association studies of gastric cancer (1423 cases, 3,14,193 controls), plasma lipidomics (179 molecular species), and 731 immune cell phenotypes. Independent, genome-wide significant single-nucleotide variants served as instrumental variables. First, we estimated the causal effects of each plasma lipid on gastric cancer. Then, we explored the potential intermediary role of lipid-associated immune cell traits using a 2-step Mendelian randomization framework. Two lipids \u2013 phosphatidylethanolamine (18:0 0:0) and phosphatidylcholine (O-18:0 16:1) \u2013 were causally associated with a lower risk of gastric cancer. Three immune cell traits (CD8br and CD8dim %leukocyte, IgD on IgD+ CD38\u2212 and CD3 on CD28\u2212 CD8br) similarly showed protective effects. In contrast, phosphatidylcholine (O-16:1 18:2), triacylglycerol (49:1), triacylglycerol (56:3), and triacylglycerol (56:4) increased gastric cancer risk, as did immune traits such as TD DN (CD4\u2212CD8\u2212)AC, CD19 on memory B cell, CD28 on CD39+ activated Treg, CD45 on CD4+, CD127 on CD28+DN(CD4\u2212CD8\u2212) and CCR2 on CD14+CD16+ monocyte. Exploratory mediation analyses found no statistically significant evidence that immune cell traits mediated the effects of plasma lipids on gastric cancer risk. Specific phosphatidylethanolamines and phosphatidylcholines confer protection against gastric cancer, whereas several triacylglycerols increase risk. However, exploratory mediation analyses provided no statistically significant evidence that immune cell traits mediated these associations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000050371","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:07:30Z","timestamp":1789142850000},"page":"e50371","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Plasma lipid species, immune cell traits, and gastric cancer risk"],"prefix":"10.1097","volume":"105","author":[{"given":"Peng","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Hepatobiliary Surgery, Mudanjiang Tumor Hospital, Mudanjiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianqi","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of General Surgery, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3606-982X","authenticated-orcid":false,"given":"Yongxu","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of General Surgery, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261028","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","article-title":"Gastric cancer.","volume":"396","author":"Smyth","year":"2020","journal-title":"Lancet"},{"key":"R2-20261028","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"R3-20261028","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13045-023-01451-3","article-title":"Gastric cancer treatment: recent progress and future perspectives.","volume":"16","author":"Guan","year":"2023","journal-title":"J Hematol Oncol"},{"key":"R4-20261028","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.21037\/tcr-21-655","article-title":"Aberrant lipid metabolism reprogramming and immune microenvironment for gastric cancer: a literature review.","volume":"10","author":"Cui","year":"2021","journal-title":"Transl Cancer Res"},{"key":"R5-20261028","doi-asserted-by":"crossref","first-page":"216305","DOI":"10.1016\/j.canlet.2023.216305","article-title":"HKDC1 reprograms lipid metabolism to enhance gastric cancer metastasis and cisplatin resistance via forming a ribonucleoprotein complex.","volume":"569","author":"Zhao","year":"2023","journal-title":"Cancer Lett"},{"key":"R6-20261028","doi-asserted-by":"crossref","first-page":"e0288111","DOI":"10.1371\/journal.pone.0288111","article-title":"Association between blood lipid levels and risk of gastric cancer: a systematic review and meta-analysis.","volume":"18","author":"Xu","year":"2023","journal-title":"PLoS One"},{"key":"R7-20261028","doi-asserted-by":"crossref","first-page":"445","DOI":"10.4143\/crt.2020.599","article-title":"Associations of serum lipid level with gastric cancer risk, pathology, and prognosis.","volume":"53","author":"Pih","year":"2021","journal-title":"Cancer Res Treat"},{"key":"R8-20261028","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1038\/s41467-022-32570-z","article-title":"Predicting response to immunotherapy in gastric cancer via multi-dimensional analyses of the tumour immune microenvironment.","volume":"13","author":"Chen","year":"2022","journal-title":"Nat Commun"},{"key":"R9-20261028","doi-asserted-by":"crossref","first-page":"1073274821997430","DOI":"10.1177\/1073274821997430","article-title":"The Anti-PD-1\/PD-L1 immunotherapy for gastric esophageal cancer: a systematic review and meta-analysis and literature review.","volume":"28","author":"Chen","year":"2021","journal-title":"Cancer Control"},{"key":"R10-20261028","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/jrsm.1346","article-title":"Meta-analysis and mendelian randomization: a review.","volume":"10","author":"Bowden","year":"2019","journal-title":"Res Synth Methods"},{"key":"R11-20261028","doi-asserted-by":"crossref","first-page":"k601","DOI":"10.1136\/bmj.k601","article-title":"Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians.","volume":"362","author":"Davies","year":"2018","journal-title":"BMJ"},{"key":"R12-20261028","doi-asserted-by":"crossref","first-page":"6934","DOI":"10.1038\/s41467-023-42532-8","article-title":"Genome-wide association analysis of plasma lipidome identifies 495 genetic associations.","volume":"14","author":"Ottensmann","year":"2023","journal-title":"Nat Commun"},{"key":"R13-20261028","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/s41588-020-0684-4","article-title":"Complex genetic signatures in immune cells underlie autoimmunity and inform therapy.","volume":"52","author":"Orr\u00f9","year":"2020","journal-title":"Nat Genet"},{"key":"R14-20261028","doi-asserted-by":"crossref","first-page":"4671","DOI":"10.7150\/thno.74770","article-title":"Plasma lipids signify the progression of precancerous gastric lesions to gastric cancer: a prospective targeted lipidomics study.","volume":"12","author":"Liu","year":"2022","journal-title":"Theranostics"},{"issue":"Suppl 2","key":"R15-20261028","doi-asserted-by":"crossref","first-page":"S206","DOI":"10.1245\/s10434-015-4459-6","article-title":"Overexpression of lysophosphatidylcholine acyltransferase 1 and concomitant lipid alterations in gastric cancer.","volume":"23","author":"Uehara","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"R16-20261028","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13045-023-01498-2","article-title":"Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics.","volume":"16","author":"Jin","year":"2023","journal-title":"J Hematol Oncol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050371","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T06:00:42Z","timestamp":1793167242000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050371"}},"subtitle":["A Mendelian randomization study"],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":16,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000050371","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]},"assertion":[{"value":"2025-06-17","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-07","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}